Switching from standard to dose-dense chemotherapy in front-line treatment of advanced ovarian cancer: a retrospective study of feasibility and efficacy

Por Milani, Andrea, Kristeleit, Rebecca, McCormack, Mary, Raja, Fharat, Luvero, Daniela, Widschwendter, Martin, MacDonald, Nicola, Mould, Tim, Olatain, Adeola, Hackshaw, Allan, Ledermann, Jonathan A
Publicado no ESMO Open (2017)

Cancer and liver cirrhosis: implications on prognosis and management

Por Pinter, Matthias, Trauner, Michael, Peck-Radosavljevic, Markus, Sieghart, Wolfgang
Publicado no ESMO Open (2016)

Update on clinical research and state of the art management of patients with advanced sarcomas and GIST

Por Metaxas, Yannis, Oikonomopoulos, Georgios, Pentheroudakis, George
Publicado no ESMO Open (2016)

Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial...

Por Ricotta, Riccardo, Verrioli, Antonella, Ghezzi, Silvia, Porcu, Luca, Grothey, A, Falcone, Alfredo, Van Cutsem, Eric, Argilés, Guillem, Adenis, Antoine, Ychou, Marc, Barone, Carlo, Bouché, Olivier, Peeters, Marc, Humblet, Yves, Mineur, Laurent, Sobrero, Alberto F, Hubbard, Joleen M, Cremolini, Chiara, Prenen, Hans, Tabernero, Josep, Jarraya, Hajer, Mazard, Thibault, Deguelte-Lardiere, Sophie, Papadimitriou, Konstantinos, Van den Eynde, Marc, Pastorino, Alessandro, Redaelli, Daniela, Bencardino, Katia, Funaioli, Chiara, Amatu, Alessio, Carlo-Stella, Giulia, Torri, Valter, Sartore-Bianchi, Andrea, Vanzulli, Angelo, Siena, Salvatore
Publicado no ESMO Open (2017)

Predictive and prognostic biomarkers of targeted agents and modern immunotherapy in renal cell carcinoma

Por Rodriguez-Vida, Alejo, Strijbos, Michiel, Hutson, Thomas
Publicado no ESMO Open (2016)

Cancer genome: highlights of a Nature Medicine perspective

Por Voest, Emile
Publicado no ESMO Open (2016)

Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?

Por Paglialunga, Luca, Salih, Zena, Ricciuti, Biagio, Califano, Raffaele
Publicado no ESMO Open (2016)

Recent advances in the biology of human circulating tumour cells and metastasis

Por Gkountela, Sofia, Szczerba, Barbara, Donato, Cinzia, Aceto, Nicola
Publicado no ESMO Open (2016)

Successful osimertinib treatment for leptomeningeal carcinomatosis from lung adenocarcinoma with the T790M mutation of EGFR

Por Sakai, Hitomi, Hayashi, Hidetoshi, Iwasa, Tsutomu, Hasegawa, Yoshikazu, Takeda, Masayuki, Nakagawa, Kazuhiko
Publicado no ESMO Open (2017)

The ‘Charter of Rights for Family Caregivers’. The role and importance of the caregiver: an Italian proposal

Por Antonella, Sisto, Flavia, Vicinanza, Daniela, Tartaglini, Giuseppe, Tonini, Daniele, Santini
Publicado no ESMO Open (2017)

Life-threatening colitis and complete response with ipilimumab in a patient with metastatic BRAF-mutant melanoma and rheumatoid arthritis

Por Aya, Francisco, Gaba, Lydia, Victoria, Ivan, Fernandez-Martinez, Aranzazu, Ruiz-Esquide, Virginia, Pineda, Estela, Tosca, Monica, Viladot, Margarita, Pereira, Veronica, Malvehy, Josep, Prat, Aleix, Arance, Ana
Publicado no ESMO Open (2016)

Unravelling signal escape through maintained EGFR activation in advanced non-small cell lung cancer (NSCLC): new treatment options

Por Remon, Jordi, Besse, Benjamin
Publicado no ESMO Open (2016)

Challenge of cancer in the elderly

Por Marosi, Christine, Köller, Marcus
Publicado no ESMO Open (2016)

Highlights in breast cancer from ASCO 2016

Por Cardoso, Fatima
Publicado no ESMO Open (2016)

Emerging challenges of advanced squamous cell lung cancer

Por Zhang, Yi-Chen, Zhou, Qing, Wu, Yi-Long
Publicado no ESMO Open (2017)

Immune checkpoint inhibitors for advanced non-small cell lung cancer: emerging sequencing for new treatment targets

Por Aguiar, Pedro Nazareth, De Mello, Ramon Andrade, Barreto, Carmelia Maria Noia, Perry, Luke Alastair, Penny-Dimri, Jahan, Tadokoro, Hakaru, Lopes, Gilberto de Lima
Publicado no ESMO Open (2017)

Cancer in pregnancy: disentangling treatment modalities

Por Zagouri, Flora, Dimitrakakis, Constantine, Marinopoulos, Spyridon, Tsigginou, Alexandra, Dimopoulos, Meletios-Athanassios
Publicado no ESMO Open (2016)

Renal insufficiency and cancer treatments

Por Launay-Vacher, Vincent, Janus, Nicolas, Deray, Gilbert
Publicado no ESMO Open (2016)

NTRK gene fusions as novel targets of cancer therapy across multiple tumour types

Por Amatu, Alessio, Sartore-Bianchi, Andrea, Siena, Salvatore
Publicado no ESMO Open (2016)

Can we predict toxicity and efficacy in older patients with cancer? Older patients with colorectal cancer as an example

Por Winther, Stine Braendegaard, Jørgensen, Trine Lembrecht, Pfeiffer, Per, Qvortrup, Camilla
Publicado no ESMO Open (2016)